Pembrolizumab And Berahyaluronidase Alfa 43624-0030
Product NDC
43624-0030- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 19, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Berahyaluronidase Alfa | 2000 U/mL |
| Pembrolizumab | 165 mg/mL |
Packaging Options(1)
221 VIAL in 1 TRAY (43624-030-01) / 2.4 mL in 1 VIAL